ABBV Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +29.44% AbbVie Inc. price and volume Combination chart with 2 data series. Chart represents AbbVie Inc. price and volume over 1Y period View as data table, AbbVie Inc. price and volume The chart has 2 X axes displaying...
Latest news: AbbVie Inc. Global markets live: Boeing, Robinhood, Blackstone, Nestlé, ABB...Oct. 17 BMO Capital Adjusts Price Target on AbbVie to $220 From $214Oct. 17MT AbbVie: FDA approval for Parkinson's diseaseOct. 17CF AbbVie Gets FDA OK for Vyalev in Adults With Advanced Park...
在过去的三个月中,11位分析师对AbbVie(纽交所:ABBV)发表了评级,提供了从看好到看淡的多元化观点。下表提供了他们的快照 Benzinga05:01 艾伯维公司被花旗集团维持为买入 艾伯维公司维持买入评级 道琼斯02:32· 评级/大行评级 艾伯维公司分析师评级 日期 上行/下行 分析师公司 价格目标变动 评级变动 先前/当前评级 ...
Current Price $82.21 NASDAQ: EXEL Exelixis Market Cap $7B Current Price $26.06 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
Get the latest AbbVie Inc. (ABBV) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
AbbVie Inc. (ABBV.NYSE): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock AbbVie Inc. | Nyse: ABBV | Nyse
Schlüsseldaten Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently ...
bla00109: $ABBV any news to explain price drop? Visit the Trading Forum to join in the discussion. Stock Price$187.74 Change-1.01% Volume1,972,270 AbbVie Inc is a research-based biopharmaceutical company. Its products are used to treat diseases including rheumatoid arthritis, psoriasis, Crohn'...
Not only is AbbVie attractively valued in comparison with the broad market, but also by historical standards for the company. As cash flows have increased and the stock price has remained under pressure over the past several years, valuation metrics such as price to operating cash flow are curr...
Currently, the analyst consensus on AbbVie is a Strong Buy with an average price target of $186.17, implying a 16.7% upside from current levels. In a report issued on April 26, Bank of America Securities also reiterated a Hold rating on the stock with a $...